PATENT CLAIM ANALYSIS

Application Number: 16040393
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "217000"]

Abstract:
The invention provides compositions and methods of treating autism. Specifically, the invention relates to treating the core symptoms of autism by administering α-methyl-DL-tyrosine.

Claim (Index 3):
The method of  claim 1 , wherein the composition comprises \u03b1-methyl-DL-tyrosine in an amount of about 100 mg (w/w/).

Metadata:
- Claim Count in Document: 47.0
- Percentile: 95.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524334', '15029596', '14415978', '15059602', '13945384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7388637253362013
- 35 USC 102 Novelty (BERT): 0.5146551972529336
- Combined Prediction Score: 0.7164428725278745
- Mean Citation Score: 238.61677200000003
- Max Citation Score: 273.71497
- Similarity Product: 203.4410041603863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test